Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-2320
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma ; day:26 ; month:4 ; year:2021 ; pages:1-7
Neurosurgical review ; (26.4.2021), 1-7
- Creator
-
Dubinski, Daniel
Won, Sae-Yeon
Voss, Martin
Keil, Fee
Miesbach, Wolfgang
Behmanesh, Bedjan
Dosch, Max
Baumgarten, Peter
Bernstock, Joshua D.
Seifert, Volker
Freiman, Thomas Michael
Geßler, Florian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10143-021-01539-9
- URN
-
urn:nbn:de:101:1-2021061719053197805762
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dubinski, Daniel
- Won, Sae-Yeon
- Voss, Martin
- Keil, Fee
- Miesbach, Wolfgang
- Behmanesh, Bedjan
- Dosch, Max
- Baumgarten, Peter
- Bernstock, Joshua D.
- Seifert, Volker
- Freiman, Thomas Michael
- Geßler, Florian
- SpringerLink (Online service)
Other Objects (12)
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Heparin and Venous Thrombo-Embolism
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Increased Heparin Clearance in Experimental Pulmonary Embolism
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Heparin and Venous Thrombo-Embolism
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Increased Heparin Clearance in Experimental Pulmonary Embolism
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Heparin and Venous Thrombo-Embolism
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis
Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Increased Heparin Clearance in Experimental Pulmonary Embolism
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis